Home › Trial NCT00324714
Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
- Trial IDNCT00324714
- StatusWithdrawn
- PhasePhase 3
- Study typeInterventional
- SponsorETOP IBCSG Partners Foundation
- Enrollment—
- Start date2003-02
- ConditionsBreast Cancer · Osteoporosis
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.